- Home
- VRAX vs VMAR Comparison
VRAX vs VMAR Comparison
Compare VRAX & VMAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRAX
- VMAR
- Stock Information
- Founded
- VRAX 2013
- VMAR 1995
- Country
- VRAX United Kingdom
- VMAR Canada
- Employees
- VRAX N/A
- VMAR N/A
- Industry
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- VMAR Marine Transportation
- Sector
- VRAX Health Care
- VMAR Industrials
- Exchange
- VRAX Nasdaq
- VMAR Nasdaq
- Market Cap
- VRAX 5.9M
- VMAR 5.1M
- IPO Year
- VRAX 2022
- VMAR 2020
- Fundamental
- Price
- VRAX $1.09
- VMAR $6.19
- Analyst Decision
- VRAX Strong Buy
- VMAR Strong Buy
- Analyst Count
- VRAX 1
- VMAR 1
- Target Price
- VRAX $3.00
- VMAR $2,700.00
- AVG Volume (30 Days)
- VRAX 300.7K
- VMAR 221.2K
- Earning Date
- VRAX 02-05-2025
- VMAR 04-08-2025
- Dividend Yield
- VRAX N/A
- VMAR N/A
- EPS Growth
- VRAX N/A
- VMAR N/A
- EPS
- VRAX N/A
- VMAR N/A
- Revenue
- VRAX $84,872.00
- VMAR $1,612,492.00
- Revenue This Year
- VRAX $5,169.18
- VMAR $120.43
- Revenue Next Year
- VRAX $66.97
- VMAR N/A
- P/E Ratio
- VRAX N/A
- VMAR N/A
- Revenue Growth
- VRAX 7.03
- VMAR N/A
- 52 Week Low
- VRAX $0.60
- VMAR $4.04
- 52 Week High
- VRAX $9.00
- VMAR $1,039.50
- Technical
- Relative Strength Index (RSI)
- VRAX 48.47
- VMAR 47.55
- Support Level
- VRAX $0.91
- VMAR $6.11
- Resistance Level
- VRAX $1.09
- VMAR $6.82
- Average True Range (ATR)
- VRAX 0.11
- VMAR 0.79
- MACD
- VRAX 0.03
- VMAR 0.19
- Stochastic Oscillator
- VRAX 51.92
- VMAR 57.29
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.
About VMAR Vision Marine Technologies Inc.
Vision Marine Technologies Inc is in the business of designing and manufacturing electric outboard powertrain systems, power boats, and related technology and the renting of electric boats. The different models of the powerboats and electric boats manufactured by the company include Bruce 22, Fantail 217, Volt 180, and others. The company operates in two reportable business segments; Sale of electric boats and Rental of electric boats. The majority of the revenue for the company is generated from the Sale of electric boats segment. Geographically, the company generates revenue from its business in Canada, USA and other countries. A substantial portion of the overall revenue is generated from its business in USA.